Use the tags below for filtering
New methods and software tools
We investigate the molecular landscape of the morphotypes.
Exploiting the gut microbiome for cancer diagnosis and treatment
Region-based biomarkers.
The aim is to improve prognostic and predictive stratification of CRC by defining microbial-immune-molecular CRC pathophenotypes and correlate them with tumour aggressiveness and patient prognosis.